Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GTPase IMAP family member 4 is a small GTPase enzyme classified within the GTP-binding superfamily and the immunity-associated nucleotide (IAN) subfamily. It is prominently expressed in lymphocytes and plays roles in immune cell development, regulation of apoptosis in thymocytes, and cytokine secretion by T-helper cells. The gene is found clustered with other IAN subfamily members on chromosome 7q36.1. Although associated with immune-related diseases such as Behçet syndrome and alveolar periostitis, there are currently no direct drugs or established biomarkers targeting GIMAP4. Its essential biological functions highlight its importance in immune regulation and apoptosis signaling in the thymus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GTPase IMAP family member 4 (GIMAP4).